Time-series clustering analysis for treatment pattern of lasmiditan for 2 years from the initial prescription
This nationwide claims-based study provides the first real-world evidence of long-term lasmiditan prescribing patterns. The identification of three distinct trajectories highlights the heterogeneity of clinical practice. It underscores the need for further research on lasmiditan's optimal use, particularly regarding combination therapy and potential medication overuse.
Authors
- Masahito Katsuki (ORCID: https://orcid.org/0000-0002-0192-5430)
- Yasuhiko Matsumori (ORCID: https://orcid.org/0000-0001-5852-0146)
- Taisuke Ichihara
- Yuya Yamada
Institutions
- Science Foundation Ireland (IE)
- Japan Lifeline (Japan) (JP)
- Dublin City University (IE)
- Nagaoka University of Technology (JP)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562864251381900
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Eli Lilly and Company
- European Commission
- Eli Lilly Japan